( November 4, 2026, 2:55 PM EST) -- PHILADELPHIA — The Third Circuit U.S. Court of Appeals denied a biotechnology company and its top officer’s petition for rehearing or rehearing en banc of a decision vacating the dismissal of investors’ class action alleging that misleading financial disclosures caused investment losses when corrected. In its earlier decision, the panel held that the lower court improperly relied on a categorical materiality rule inconsistent with U.S. Supreme Court precedent....